Clinical trial

Aromatase Inhibitor Host Factors Study

NCT01669343

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-10-01

PhaseNA

Study timeline

Study start (actual)2012-10-01Date precision: month

Registry last updated2021-05-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Neoplasmsunresolved

Interventions

LetrozoleDRUG · verified · RxNorm: letrozole

Sponsors & collaborators

Samuel Lunenfeld Research Institute, Mount Sinai Hospitallead sponsor

Mapped research locations

TorontoOntario, Canada3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01669343 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.